Oncimmune

2 known investors

Oncimmune operates ImmunoINSIGHTS, an antibody/autoantibody biomarker discovery platform that profiles antibodies from low-volume biological samples using a library of ~9,000 human antigens and machine learning analytics. It serves clients developing precision medicine, providing biomarker discovery, bioinformatics, and multiomics data integration.

AI & Machine LearningBiotechHealthtech